prikaz prve stranice dokumenta Liver transplantation in patients with hilar cholangiocarcinoma : single center experience
  Download
PDF 3.86 MB
Other - Conference abstract
Liver transplantation in patients with hilar cholangiocarcinoma : single center experience
In: Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”. Oslo: EASL, 2017. pp. 205-206. urn:nbn:hr:264:621002
Dinjar Kujundžić, Petra; Ledinski, Ivan; Ostojić, Ana; Sobočan, Nikola; Gašparov, Slavko; Kocman, Branislav; Jadrijević, Stipislav; Mikulić, Danko; Filipec Kanižaj, Tajana

Cite this document

Dinjar Kujundžić, P., Ledinski, I., Ostojić, A., Sobočan, N., Gašparov, S., Kocman, B. ... Filipec Kanižaj, T. (2017). Liver transplantation in patients with hilar cholangiocarcinoma : single center experience. Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments” (pp. 205-206). Oslo: EASL. Retrieved from https://urn.nsk.hr/urn:nbn:hr:264:621002

Dinjar Kujundžić, Petra, et al. "Liver transplantation in patients with hilar cholangiocarcinoma : single center experience." Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”, EASL, 2017, pp. 205-206. https://urn.nsk.hr/urn:nbn:hr:264:621002

Dinjar Kujundžić, Petra, Ivan Ledinski, Ana Ostojić, Nikola Sobočan, Slavko Gašparov, Branislav Kocman, Stipislav Jadrijević, Danko Mikulić and Tajana Filipec Kanižaj. "Liver transplantation in patients with hilar cholangiocarcinoma : single center experience." In Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”, 205-206. Oslo: EASL, 2017. Accessed 2025 April 01. https://urn.nsk.hr/urn:nbn:hr:264:621002

Dinjar Kujundžić, P., et al. (2017) 'Liver transplantation in patients with hilar cholangiocarcinoma : single center experience', Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”, EASL, Oslo, pp. 205-206. Available at: https://urn.nsk.hr/urn:nbn:hr:264:621002 (Accessed 01 April 2025)

Dinjar Kujundžić P, Ledinski I, Ostojić A, Sobočan N, Gašparov S, Kocman B, and sur.. Liver transplantation in patients with hilar cholangiocarcinoma : single center experience. Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”. Oslo: EASL; 2017. Pp. 205-206. [cited 2025 April 01] Available at: https://urn.nsk.hr/urn:nbn:hr:264:621002

P. Dinjar Kujundžić, et al., "Liver transplantation in patients with hilar cholangiocarcinoma : single center experience", Programme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments” Oslo: EASL, 2017. [Online] Available at: https://urn.nsk.hr/urn:nbn:hr:264:621002 [Accessed: 01 April 2025]

Please login to the repository to save this object to your list.
Metadata
Title (english)Liver transplantation in patients with hilar cholangiocarcinoma : single center experience
AuthorPetra Dinjar Kujundžić
AuthorIvan Ledinski
AuthorAna Ostojić
AuthorNikola Sobočan
AuthorSlavko Gašparov
AuthorBranislav Kocman
AuthorStipislav Jadrijević
AuthorDanko Mikulić
AuthorTajana Filipec Kanižaj
Author's institution(Merkur University Hospital)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Abstract (english)
Introduction: Liver transplantation (LT) in patients with hilar cholangiocarcinoma (hCC) is a controversial method of treatment. However, in selected number of patients provides acceptable results. Aims: The aim of this study is to present the outcome of liver transplantation in patients with hCC in our Center. Material and Methods: A retrospective analysis was performed on data of transplanted patients due to hCC between 2010 and 2017 in Clinical Hospital Merkur, Croatia. Data were evaluated... More regarding demographic, clinical, etiological, histopathologic stage, waiting time (WT) on list and outcome. Results: In total period 784 liver transplants were performed, of which 3.4% (n = 27) were made due to hCC. Mean age was 61 ± 7.98 years and majority of patients were male (51.9%). 65.2% of patients were exposed to endobiliary drainage before LT. Primary sclerosing cholangitis was present in only one patient, while the majority of patients (96.3%) did not have associated liver disease. The median time on waiting list was very short and amounted 16.22 days (0-89). The majority of patients were Bismuth type III (44%), followed by type II (24%). On the histopathological examination 65% of cases showed tumor size less than 30 mm. Comparison of tumor size greater and less than 30 mm showed equal shares of lymphovascular invasion, perineural invasion, the invasion of surrounding fatty tissue and early tumor recurrence. The Mayo Clinic protocol of neoadjuvant chemoradiation was not performed. Median follow-up after LT was 16.7 months (range from 0.2 to 73.8). Overall tumor recurrence was 26.1%. There wasn’t significant difference in tumors size, lymphovascular invasion, perineural invasion and the invasion of surrounding fatty tissue between group with or without hCC recurrence. 1- and 3-year survival rate after transplantation was 21/27 (77, 7%) and 15/27 (55, 5%), respectively ; with 55.6% of death rate due to early recurrence of hCC and 44.4% rate due to postoperative mortality. Only four patients live longer than five years. Conclusions: Orthotopic liver transplantation might be applicable for a highly selected subgroup, emphasizing the need for better adjuvant strategies. To define prognostic factors for hCC recurrence, larger cohort of patients need to be analyzed. Current high donor rate in Croatia provides hCC patients short WT on the list for LT. Less
Keywords (english)
Languageenglish
Publication typeOther - Conference abstract
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Publication titleProgramme&Abstracts: EASL Monothematic Conference “Cholangiocytes in Health and Disease: from Basic Science to Novel Treatments”
Numberingvol. -, pp. 205-206
URN:NBNurn:nbn:hr:264:621002
Publication2017
ConferenceTitle: EASL Monothematic Conference “CHOLANGIOCYTES IN HEALTH AND DISEASE: FROM BASIC SCIENCE TO NOVEL TREATMENTS”
Location: Oslo, Norway
Organizer: EASL: the European Association for the Study of the Liver
Start date: 2017-06-09
End date: 2017-06-11
Assembly type: Poster
Document URLhttp://www.easloffice.eu/events/2017_Oslo/ebook/mobile/index.html#p=205
Type of resourceText
PublisherEASL
Publishing placeOslo
Access conditionsOpen access
Terms of useLicence Attribution 3.0 Unported (CC BY 3.0) icon
Created on2021-07-30 07:52:53
accessibility

closeAccessibilityrefresh

If you wish to permanently save changes, click on Save, if not - your settings will be reset when you restart the browser.